Therapeutic levels of intravenous procainamide in neonates: A retrospective assessment

Pharmacotherapy

Volumn 26, Issue 12 I, 2006, Pages 1687-1693

  Moffett, Brady S ^a   Cannon, Bryan C ^b   Friedman, Richard A ^b   Kertesz, Naomi J ^b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Dosing; N acetylprocainamide; NAPA; Neonates; Pharmacokinetics; Procainamide

Indexed keywords

ACECAINIDE; CREATININE; PROCAINAMIDE;

ACETYLATION; AGE; ARTICLE; ATRIOVENTRICULAR JUNCTION ARRHYTHMIA; CALCULATION; CLINICAL ARTICLE; CONTINUOUS INFUSION; CREATININE CLEARANCE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; EVALUATION; GASTROINTESTINAL SYMPTOM; HEART ATRIUM FLUTTER; HEART PROARRHYTHMIA; HEMODYNAMICS; HUMAN; HYPOTENSION; MUSCLE WEAKNESS; NEWBORN; RASH; RECOMMENDED DRUG DOSE; REENTRY ARRHYTHMIA; RETROSPECTIVE STUDY; SIDE EFFECT; STEADY STATE; SUPRAVENTRICULAR TACHYCARDIA; SYSTEMIC LUPUS ERYTHEMATOSUS;

ACECAINIDE; ANTI-ARRHYTHMIA AGENTS; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; METABOLIC CLEARANCE RATE; PROCAINAMIDE; RETROSPECTIVE STUDIES;

EID: 33845373154     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.26.12.1687     Document Type: Article

References (21)

1. Wong KK, Potts JE, Etheridge SP, Sanatani S. Medications used to manage supraventricular tachycardia in the infant: a North American survey. Pediatr Cardiol 2006;27:199-203.
2. Bryson SM, Leson CL, Irwin DB, Trope AE, Hosking MCK. Therapeutic monitoring and pharmacokinetic evaluation of procainamide in neonates. Ann Pharmacother 1991;25:68-71.
3. Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976;58:259-63.
4. Winter ME, ed. Basic clinical pharmacokinetics, 3rd ed. Philadelphia: Lippincott, Williams, and Wilkins, 1994.
5. Singh S, Gelband H, Mehta AV, Kessler K, Casta A, Pickoff AS. Procainamide elimination kinetics in pediatric patients. Clin Pharmacol Ther 1982;32:607-11.
6. Kertesz NJ, Friedman RA, Fenrich AL, Garson A. Current management of the infant and child with supraventricular tachycardia. Cardiol Rev 1998;6:221-30.
7. Taketomo C, Hodding JH, Kraus DM. Pediatric dosage handbook. Cleveland, OH: Lexi-Comp, Inc., 2005.
8. Engel TR, Meister SG, Luck JC. Modification of ventricular tachycardia by procainamide in patients with coronary artery disease. Am J Cardiol 1980;46:1033-8.
9. Giardina EG, Fenster PE, Bigger JT Jr, Mayersohn M, Perrier D, Marcus FI. Efficacy, plasma concentrations and adverse effects of a new sustained release procainamide preparation. Am J Cardiol 1980;46:855-62.
10. Greenspan AM, Horowitz LN, Spielman SR, Josephson ME. Large dose procainamide therapy for ventricular tachyarrhythmia. Am J Cardiol 1980;46:453-62.
11. Nolan PE Jr. Pharmacokinetics and pharmacodynamics of intravenous agents for ventricular arrhythmias. Pharmacotherapy 1997;17(2 pt 2):S65-75.
12. Reidenberg MM, Drayer DE, Levy M, et al. Polymorphic acetylation of procainamide in man. Clin Pharmacol Ther 1975;17:722-30.
13. Graffner C, Johnson C, Sjogren J. Pharmacokinetics of procainamide intravenously and orally as conventional and slow-release tablets. Clin Pharmacol Ther 1975;17:414-23.
14. Gibson TP, Atkinson AJ, Matusik E, Nelson LD, Briggs WA. Kinetics of procainamide and N-acetylprocainamide in renal failure. Kidney Int 1977:12;422-9.
15. Gallini F, Maggio L, Romagnoli C, Marrocco G, Tortorolo G. Progression of renal function in preterm neonates with gestational age of 32 weeks or less. Pediatr Nephrol 2000;15:119-24.
16. Aperia A, Broberger O, Elinder G, Herin P, Zetterstrom R. Postnatal development of renal function in pre-term and full-term infants. Acta Paediatr Scand 1981;70:183-7.
17. Lima JJ, Kuritzky PM, Schentag JJ, Jusko WJ. Fetal uptake and neonatal disposition of procainamide and its acetylated metabolite: a case report. Pediatrics 1978;61:491-3.
18. Mandapati R, Byrum CJ, Kavey REW, et al. Procainamide for rate control of postsurgical junctional tachycardia. Pediatr Cardiol 2000;21:123-8.
19. Walsh EP, Saul JP, Sholler GF, et al. Evaluation of a staged treatment protocol for rapid automatic junctional tachycardia after operation for congenital heart disease. J Am Coll Cardiol 1997;29:1046-53.
20. Dhala A, Lewis DA, Garland J, Pelech AN. Verapamil sensitive incessant ventricular tachycardia in the newborn. Pacing Clin Electrophysiol 1996;19(11 pt 1):1652-4.
21. Bauer LA, Black DJ, Lill JS, Garrison J, Raisys VA, Hooton TM. Levofloxacin and ciprofloxacin decrease procainamide and N-acetylprocainamide renal clearances. Antimicrob Agents Chemother 2005;49:1649-51.